The global endoscopic ultrasound (EUS) needles market is projected to expand at a CAGR of 6.2% from 2023 to 2031, reaching a valuation of USD 266.1 million by the end of the forecast period, according to a report by Transparency Market Research (TMR). The market was valued at USD 152.3 million in 2022, with growth fueled by the increasing prevalence of gastrointestinal cancer, the expanding adoption of minimally invasive surgeries, and continuous technological advancements in robotic and endoscopic procedures.
Analyst Viewpoint
The demand for endoscopic ultrasound needles is growing due to their critical role in diagnostic imaging and tissue sampling for various abdominal and pulmonary conditions, particularly stomach, pancreatic, liver, and lung cancers. The rising incidence of stomach cancer, attributed to aging, dietary habits, smoking, and excessive alcohol consumption, is a key driver of market expansion.
The increasing preference for robotic surgeries and minimally invasive diagnostic techniques presents lucrative opportunities for manufacturers. Companies are actively investing in research and development (R&D) to introduce next-generation EUS-guided fine-needle aspiration (FNA) and biopsy (FNB) devices with enhanced accuracy. Market players are also focusing on securing regulatory approvals and expanding their portfolios with narrow-band imaging (NBI) technology to improve procedural precision and efficiency.
Gain an understanding of key findings from our Report in this sample –
Market Overview
Endoscopic ultrasound needles are thin, specialized devices used for precise aspiration and biopsy procedures in gastroenterology and pulmonology. These needles, attached to an endoscopic tube, allow fluid or tissue extraction for pathological examination. Their primary applications include tumor diagnosis, infection detection, and targeted drug delivery in abdominal and thoracic organs such as the pancreas, liver, and lungs.
The market is segmented into aspiration needles (EUS-FNA) and biopsy needles (EUS-FNB), both of which play a crucial role in detecting and diagnosing gastrointestinal and hepatobiliary diseases. Physicians select the appropriate needle type based on the organ and medical condition being evaluated, ensuring precise diagnosis and minimally invasive treatment planning.
Market Dynamics
The increasing prevalence of gastrointestinal (GI) cancer is a major driver of market growth. Gastrointestinal malignancies, including stomach, pancreatic, and liver cancers, can lead to severe complications such as abdominal pain, bleeding, loss of appetite, and digestive issues. Poor dietary habits, smoking, alcohol consumption, and obesity are key contributors to the rising incidence of GI cancer, driving demand for endoscopic ultrasound (EUS) procedures.
Endoscopic ultrasound needles play a vital role in diagnosing gastrointestinal and hepatobiliary disorders by providing high-resolution ultrasound images and enabling real-time tissue sampling. The increase in stomach cancer cases, particularly among young adults due to dietary imbalances and alcohol consumption, has fueled the adoption of EUS-guided fine-needle procedures.
According to the National Cancer Institute, 26,500 new stomach cancer cases were estimated in 2023, accounting for 1.4% of all new cancer diagnoses. Furthermore, approximately 11,130 fatalities were projected due to this condition. The rise in pancreatic, liver, and lung cancer cases has further increased the demand for EUS-based biopsy and aspiration procedures in minimally invasive surgeries.
The rapid advancement of minimally invasive surgeries (MIS) is another crucial factor shaping market expansion. Robotic-assisted surgical systems are enabling high-definition endoscopic ultrasound imaging, allowing surgeons to perform precise biopsies and targeted drug delivery with reduced patient trauma, minimal blood loss, and faster recovery times. The growing preference for MIS among the elderly population, who are more susceptible to pancreatic and abdominal cancers, is further fueling demand for advanced EUS-guided fine-needle techniques.
According to the American Cancer Society, 64,050 individuals were expected to be diagnosed with pancreatic cancer in the U.S. in 2023, with approximately 50,550 deaths projected due to this disease. These statistics underscore the need for advanced diagnostic solutions, further driving market expansion.
Regional Outlook
According to TMR’s regional analysis, Asia Pacific emerged as the largest market for endoscopic ultrasound needles in 2022 and is anticipated to maintain its dominance throughout the forecast period. The region’s high prevalence of gastric cancer, coupled with increased healthcare spending and advancements in cancer treatments, is propelling demand for EUS-guided diagnostic and therapeutic procedures.
The National Institutes of Health (NIH) reports that Asia has exceptionally high gastric cancer incidence and mortality rates, primarily due to factors such as helicobacter pylori infection, smoking, alcohol consumption, and poor dietary habits. The increasing awareness of early cancer detection and the expansion of minimally invasive diagnostic procedures in the region are expected to boost market growth in the coming years.
Competitive Landscape
The endoscopic ultrasound needles market is witnessing rapid innovation, with leading manufacturers focusing on technological advancements, regulatory approvals, and portfolio expansion. Companies are investing heavily in developing precise biopsy needles designed for high-accuracy diagnostic and treatment procedures.
Key players operating in the market include Olympus Corporation, Medtronic, Cook Group, Boston Scientific Corporation, CONMED Corporation, Medi-Globe GmbH, and ACE Medical Devices Pvt. Ltd. These firms are actively enhancing their product offerings, collaborating with healthcare institutions, and investing in R&D to introduce next-generation EUS-guided biopsy devices.
Review our comprehensive report to access critical insights –
Recent Developments
In October 2023, Olympus Corporation, a global leader in medical imaging and endoscopy solutions, launched the EVIS X1 endoscopy system. This advanced platform features narrow-band imaging (NBI) technology, enhancing visual observation of mucosal and vascular patterns, thereby improving gastrointestinal cancer diagnostics.
In September 2023, Limaca Medical secured U.S. FDA 510(k) clearance for its Precision GI Endoscopic Ultrasound (EUS) Biopsy Device. This technology offers faster and less traumatic biopsy collection for pancreatic and other life-threatening GI cancers, strengthening its position in the EUS-guided biopsy market.
Endoscopic Ultrasound Needles Market Snapshot
Market expansion is driven by rising gastrointestinal cancer cases, increasing adoption of minimally invasive surgeries, and continuous technological advancements.
The market is segmented based on product, application, and end-user. Key product categories include aspiration needles (EUS-FNA) and biopsy needles (EUS-FNB), which are extensively used in bronchial and enteral procedures. Major end-users include hospitals, specialty clinics, and ambulatory surgery centers.
The industry is witnessing significant growth across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Key countries contributing to market expansion include the United States, Canada, Germany, the United Kingdom, France, China, Japan, and India.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
